显示标签为“breast cancer”的博文。显示所有博文
显示标签为“breast cancer”的博文。显示所有博文

2016年1月20日星期三

Mota and Mata's story

In 2009, a pair of sisters from America came to Fuda Cancer Hospital. They were diagnosed with breast cancer almost at the same time and both requested to receive breast-conserving treatment. They came to FUDA and received percutaneous cryoablation, which has achieved good treatment results. Later they came to our hospital for checkups. In 2013, doctors from FUDA paid them a follow-up visit in New York, America. They have been leading a happy life.

 President Xu Kecheng  and American breast cancer sisters

Treatment experience

Researches on follow-up visits to patients by several cancer centers showed that there is no obvious difference in total survival rate between patients received radical mastectomy, breast tumor resection and patients received breast tumor resection together with radiotherapy. Given this, doctors tend to adopt conservative methods in treating breast cancer. Cryoablation is most suitable to the following cases: patients with small and isolated invasive breast cancer; patient whose tumor is smaller than 15 mm with low density and clear dividing line on a mammogram and a visible posterior wall at ultrasonography; patients with small breast tumor which is unsuitable to or intolerant of surgery or chemotherapy.

As initial treatment to small breast cancer, cryoablation has advantages as follows: 
1. The curative effect of cryoablation can be compared with that of tumor resection;
2. Patient is tolerant of cryoablation, which inflicts no pain and requires no anesthesia (or just local anesthesia ); 
3. The procedure is simple, which can be compared to CT-guided biospsy; 
4. It leaves no scar and preserves the integrity of breast appearance. It doesn’t hurt skin even if tumor is close to it;
5. It is evidenced that cryoablation can induce anti-tumor immune reaction, which is evidently beneficial to the prevention of tumor recurrence. 

Cryoablation is becoming an important way for breast cancer treatment. With regard to early stage small breast tumor, percutaneous cryoablation can achieve similar curative effect as tumor resection. As a minimally invasive treatment, cryoablation does not affect breast appearance, which is superior to the latter.

The reason why the pair of sisters came all the way to Fuda Cancer Hospital was that they wanted to receive cryoablation. They also achieved ideal curative effectat FUDA.

2016年1月6日星期三

Rena’s story Breast Cancer- New Zealand

In early 2005, the pharmacist named Rena from New Zealand presented to Guangzhou Fuda Cancer Hospital, seeking for further treatment of breast cancer with lymph node metastasis. She was recommended by Doctors from Auckland to be treated surgically, but she refused to do surgical resection of the breast because she was already 46 years old but still single. 

When she learned Fuda Cancer Hospital from the Internet, she decided to seek for treatments in Guangzhou. Upon admission, she made several requirements. First of all, the hospital shall keep her disease absolutely confidential; secondly, she strongly refused to undergo surgery; thirdly, it shall conserve the integrity of her breast. Fuda medical team carried out percutaneous cryosurgery and axillary lymph node dissection, through which her breast had been kept intact. 

In May 2006, Professor Xu Kecheng was invited to give a lecture in New Zealand, accompanied by the fully recovered enthusiastic pharmacist. Whenever professor Xu concluded his speech, she took the initiative to go onstage to share her cancer and treatment experience in China without scruples. She loosened her coat, exposing her breast and said, "My wish is to tell breast cancer patients, there are other better ways to treat breast cancer except for surgical resection!”

Rena was on the public lecture 


Rena said, “Look! How beautiful my breasts are!” 
Rena

Breast cancer

Female, 46 years old, New Zealand. She was diagnosed with breast cancer, but she refused to undergo surgical resection, so she presented to Guangzhou Fuda Cancer Hospital for percutaneous cryosurgery and axillary lymph node dissection, through which her breast had been kept intact.

Treatment experience

Surgical resection is the preferred treatment for breast cancer. In recent years, with the development of ablation and imaging techniques, non-surgical tumor ablation has been increasingly used in breast cancer treatment, among which ultrasound or MR-guided percutaneous cryoablation for breast cancer has made great progress.

The rationalities of cryotherapy for breast cancer can be listed as follows: (a) Breast cancer is a systemic disease, patient’s long-term survival or "clinical cure" not only depends on the effect of local tumor removal, but also on cancer cells elimination, so the treatment effects of surgical resection and cryoablation for local tumors are same; (2) cryosurgery can "freeze" cancer cells to release tumor antigens that stimulate the body to produce anti-tumor immunity; (3) cryotherapy is punctured by fine needle, which can keep the breast intact.

Treatment Team

Fuda Breast Cancer Treatment Treatment

Li Chaolong   Professor
Niu Lizhi   M.D.
Hu Yong   Director
Li Hongmei    Doctor
Chen Zhixian  Doctor
Xing Yanli     Doctor

2016年1月5日星期二

Improved Therapies in Breast Cancer Treatment

JOAN CITADEL CADELINA is an young Filipina who presented with breast cancer upon admission on July 08, 2009. The patient was diagnosed with left breast cancer 17 previously. When admitted, Ms. Cadelina~s symptoms were severe and had difficulty walking due to the size of the tumor. Admission diagnosis was: left breast invasive ductal carcinoma in situ stage 4, and liver metastases.

Examination: the tumor of the left breast was approximately 10 * 8cm and had begun to fester, there was light yellow liquid pus, accompanied by peculiar smell, but no significant changes in the surrounding skin color. Lymph node under the armpit measured about 8cm in diameter of about 8cm, texture was hard, it had clear boundaries, and no tenderness.

With local chemotherapy, immunotherapy, and endocrine therapy, Ms. Cadelina had significant reduction in the size of the breast tumor and axillary lymph nodes. Patients with significantly reduced compared with the previous mass, tumor ulceration has formed scar the surface of the restoration can be. While the cancer is still with the patient, the patient's condition has greatly improved while her quality of life is nearly back to normal.


Dr. Kecheng Xu is proud of Ms. Cadelina's great improvements.